Although we showed results only from the corrected BPND values, regardless of partial volume correction (i.e., corrected or uncorrected BPND values), we found no difference in mGluR1 availability between the AD and control groups across the brain, and no correlation between mGluR1 availability and MMSE scores. Here, GRM1 is linked to Alzheimer disease.